Research published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposHealth® Experienced Significant Pain Reduction

Leading musculoskeletal physicians, including David Felson, MD, MPH, Stephan Reichenbach, MD, MSc, and Peter Jüni, MD, conducted an independent, double-blinded, randomized, placebo-controlled level 1 study utilizing an individualized, non-invasive biomechanical footwear system called AposHealth®.

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — Researchers from Boston University School of Medicine, the University of Bern Switzerland, and the University of Toronto studied two hundred twenty patients with knee osteoarthritis. The patients included in the study were randomized to either AposHealth® or a similar looking control device. The primary outcome measure was the patient reported change in pain, while the secondary outcome measures included function, quality of life, gait patterns and adverse events at six months. The study demonstrated that AposHealth® significantly reduced pain associated with knee osteoarthritis, while also improving patients’ physical function and stiffness.